Status:
UNKNOWN
Evaluation of the Efficacy of Captopril Versus Propranolol and Timolol as a Treatment of Infantile Capillary Hemangioma
Lead Sponsor:
Ain Shams University
Conditions:
Infantile Hemangioma
Eligibility:
All Genders
2-12 years
Phase:
PHASE4
Brief Summary
Is to compare and evaluate the efficacy of oral captopril with oral propranolol, intralesional propranolol injection, and topical Timolol in the treatment of infantile hemangioma and their effect on v...
Detailed Description
Infantile hemangiomas are the most common benign tumor of infancy, affecting up to 10% of the pediatric population with a higher incidence in female (3:1), preterm infants, and Caucasian population. T...
Eligibility Criteria
Inclusion
- Pediatric patients younger than 12 years and older than 2 months of age with infantile hemangioma
Exclusion
- Patient with ulcerated or infected hemangioma.
- Patient younger than 2 months and older than 12 years of age.
- Patients with multiple hemangiomas.
- Any Patient with cardiovascular problems, bronchial asthma, diabetes mellitus, bilateral renal stenosis, Electrolyte disturbance, or renal impairment was excluded.
- Patients with abnormal electrocardiogram, or echocardiogram should be excluded.
- Patients who have had previous treatment for hemangioma.
Key Trial Info
Start Date :
October 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04288700
Start Date
October 1 2019
End Date
October 1 2021
Last Update
February 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vascular malformation clinic of Pediatric Surgery department of Ain Shams University.
Cairo, Egypt